Continuous Glucose Monitoring Reveals Abnormal Features of Postprandial Glycemic Excursions in Women with Polycystic Ovarian Syndrome

References

• . Sartor BM, Dickey RP. Polycystic ovarian syndrome and the metabolic syndrome. Am J Med Sci. 2005;330:336–342
   PubMed Web of Science ®Google Scholar
• . Barber TM, McCarthy MI, Franks S, Wass JA. Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol. 2007;58:34–41
   PubMedGoogle Scholar
• . Pasquali R, Patton L, Pagotto U, Gambineri A. Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome. Minerva Ginecol. 2005;57:79–85
   PubMedGoogle Scholar
• . Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest. 2006;29(3):270–280
   PubMed Web of Science ®Google Scholar
• . Espinós-Gómez JJ, Corcoy R, Calaf J. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome. Gynecol Endocrinol. 2009;25(3):199–204
   PubMed Web of Science ®Google Scholar
• . Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod. 2006;21:2027–2032
   PubMed Web of Science ®Google Scholar
• . De Leo V, Musacchio MC, Morgante G, La Marca A, Petraglia F. Polycystic ovary syndrome and type 2 diabetes mellitus. Minerva Ginecol. 2004;56(1):53–62
   PubMedGoogle Scholar
• . Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 2006;29(8):1915–1917
   PubMed Web of Science ®Google Scholar
• . Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–668
   PubMed Web of Science ®Google Scholar
• . Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuro Endocrinol Lett. 2007;28(6):807–810
   PubMed Web of Science ®Google Scholar
• . Hu W, Hu WH, Qiao J, Wang LN, Zhao CY. Characteristics of abnormal glucose tolerance in patients with polycystic ovary syndrome. Zhonghua Yi Xue Za Zhi. 2009;89:2053–2055
   PubMedGoogle Scholar
• . Barcellos CR, Rocha MP, Hayashida SA, Nery M, Marcondes JA. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome. Arq Bras Endocrinol Metabol. 2007;5:601–605
   Google Scholar
• . Hirsch IB, Armstrong D, Bergenstal RM, . Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10:232–244
   PubMed Web of Science ®Google Scholar
• . Mazze RS, Strock E, Wesley D, . Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther. 2008;10:149–159
   PubMed Web of Science ®Google Scholar
• . American Diabetes Association. Standards of medical care in diabetes–2009. Diabetes Care. 2009;32( suppl 1):S13–S61
   PubMed Web of Science ®Google Scholar
• . Chen C, Lu FC; Department of Disease Control Ministry of Health, PR China. ILSI Focal Point in China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17 suppl:1–36
   PubMed Web of Science ®Google Scholar
• . Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:390–419
   PubMedGoogle Scholar
• . World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999
   Google Scholar
• . The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47
   PubMed Web of Science ®Google Scholar
• . Zhou J, Jia WP, Yu M, . The reference values of glycemic parameters for continuous glucose monitoring and its clinical application. Zhonghua Nei Ke Za Zhi. 2007;46(3):189–192
   PubMedGoogle Scholar
• . Zhou J, Jia W, Bao Y, Ma X, . Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med Sci Monit. 2008;14:CR552–558
   PubMed Web of Science ®Google Scholar
• . Zhou J, Li H, Ran X, . Reference values for continuous glucose monitoring in Chinese subjects. Diabetes Care. 2009;32(7):1188–1193
   PubMed Web of Science ®Google Scholar
• . Rodbard D. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther. 2009;11:S55–S67
   PubMed Web of Science ®Google Scholar
• . Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094–1100
   PubMedGoogle Scholar
• . Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev. 2009;25(5):393–402
   PubMed Web of Science ®Google Scholar
• . Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Endocrinol Metab. 2008;21:109–116
   Google Scholar
• . American Diabetes Association. Postprandial blood glucose. Diabetes Care. 2001;24:775–778
   PubMed Web of Science ®Google Scholar
• . Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care. 2007;30(2):263–269
   PubMed Web of Science ®Google Scholar